Nuo Therapeutics, Inc. (AURX) › Weighted Average Diluted SharesNuo Therapeutics, Inc. (AURX) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2017-12-31: 14.65M2018-12-31: 23.28M2019-12-31: 23.72M2020-12-31: 27.31M2021-12-31: 30.30M30.30M2017-12-31Weighted Average Diluted Shares (shares)2021-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2021-12-3130.30M+10.9%2022-04-15From 2021-01-012020-12-3127.31M+15.1%2022-04-15From 2020-01-012019-12-3123.72M+1.9%2022-04-15From 2019-01-012018-12-3123.28M+58.9%2019-04-16From 2018-01-012017-12-3114.65M—2019-04-16From 2017-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)